Its values, its interview process and the questions it asks, in short episodes. Listen on a walk, then practice.
10 episodes1 free to try
No subscription needed
"Why Pfizer?" is almost guaranteed to come up in your interview, often more than once across different rounds. A weak generic answer is the single most common reason candidates lose offers. This module gives you a four-pillar framework — Mission, Science, Scale, and Personal Story — for building a "Why Pfizer" answer that lands.
Albert Bourla has named "scaling artificial intelligence across the organization" as one of Pfizer's four 2026 priorities. From the Charlie generative AI platform for marketing to Microsoft Copilot rollouts across nearly 80,000 employees to AI-driven drug discovery, Pfizer is making digital fluency a core hiring criterion. This module gives candidates the AI talking points they need.
This module covers specific behavioral questions reported by candidates who have actually interviewed at Pfizer, with full STAR-formatted answer frameworks for each. Use this as your dress rehearsal before the real interview.
Pfizer's interview process is structured and predictable, which is good news — you can prepare for it with precision. This module walks candidates through the full process from recruiter screen to offer, including the HireVue Digital Assessment, the panel "Super Day" format, and the explicit STAR rubric Pfizer interviewers use to score answers.
Pfizer is in the middle of a multi-year cost-cutting program targeting $7.7 billion in savings through 2027, with layoffs at sites from Kalamazoo to Bothell to North Carolina to Switzerland. Candidates need to walk into interviews with eyes open about the restructuring environment and ready to talk about how they thrive through change.
After a high-profile failure of its oral GLP-1 candidate danuglipron, Pfizer reset its obesity strategy with a $10 billion acquisition of Metsera in late 2025 — winning a bidding war against Novo Nordisk. The deal repositions Pfizer in the fastest-growing therapeutic area in pharma. Candidates for any cardiometabolic, commercial, R&D, or strategy role should understand this comeback story.
The 43 billion dollar Seagen acquisition, completed in December 2023, is the biggest deal in Pfizer's history and the centerpiece of its growth strategy through 2030. Any candidate interviewing for an oncology, R&D, commercial, or strategy role needs to understand this deal, the antibody-drug conjugate technology behind it, and where the integration stands today.
Pfizer is in the middle of one of the most consequential strategic pivots in big pharma — moving from the COVID-era windfall into a high-stakes race to replace patent-cliff revenue with a new generation of drugs in oncology, obesity, and rare disease. This module gives candidates the strategic context they need to talk credibly about Pfizer's direction and answer "Why now?" questions with substance.
Pfizer organizes its culture around two layers: the modern Purpose Blueprint introduced under Albert Bourla, and the older OWNIT! accountability framework that still shapes day-to-day expectations. This module explains both, why they matter for interview answers, and how to demonstrate the "act like an owner" mindset interviewers are watching for.
Pfizer's behavioral interviews are explicitly mapped to four core values: Courage, Excellence, Equity, and Joy. This module unpacks what each value really means inside Pfizer, how interviewers score answers against them, and how to make sure every STAR story you tell maps cleanly to at least one of the four.